Related Experiment Video
Updated: May 9, 2026

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
Published on: April 28, 2023
Effects of an intensive short-term diet and exercise intervention: comparison between normal-weight and obese
Christian K Roberts1, Ali Izadpanah, Siddhartha S Angadi
1Exercise and Metabolic Disease Laboratory, Translational Section, School of Nursing, University of California Los Angeles, Los Angeles, California 90095-6918, USA. croberts@ucla.edu
Insights
A short-term lifestyle intervention improved metabolic health in both normal-weight and overweight children. These findings suggest that diet and inactivity, not just obesity, drive metabolic changes, offering new management strategies.
Area of Science:
- Pediatric Endocrinology
- Metabolic Health
- Lifestyle Medicine
Background:
- Current lifestyle interventions focus on weight loss for obesity-related changes.
- The impact of such programs on normal-weight versus overweight/obese children is not well understood.
Purpose of the Study:
- To investigate if a short-term lifestyle intervention program yields different results in normal-weight compared to overweight/obese children.
- To assess changes in metabolic risk factors, including lipids, glucose homeostasis, inflammatory cytokines, and adipokines.
Main Methods:
- A 2-week intensive lifestyle intervention program was implemented.
- Participants included 19 overweight/obese children and 14 normal-weight children.
- Diet consisted of ad libitum high-fiber, low-fat intake with daily exercise (2-2.5 hours).
- Fasting serum samples were analyzed pre- and post-intervention.
Main Results:
- Only the overweight/obese group experienced weight loss (3.9%), remaining overweight.
- Both groups showed significant reductions in insulin, HOMA-IR, leptin, amylin, resistin, PAI-1, IL-6, IL-8, and TNFα.
- No correlation was found between weight change and phenotypic improvements.
Conclusions:
- A short-term, intensive lifestyle intervention effectively improves metabolic risk factors in both normal-weight and overweight/obese children.
- Obesity itself may not be the sole driver of metabolic abnormalities; dietary intake and physical inactivity play crucial roles.
- These findings support weight loss-independent management of cardiometabolic risk in pediatric populations.
Abstract:
Lifestyle intervention programs currently emphasize weight loss secondary to obesity as the primary determinant of phenotypic changes. We examined whether the effects of a short-term lifestyle intervention program differ in normal-weight versus overweight/obese children. Nineteen overweight/obese (O; BMI = 33.6 ± 1.9 kg/m(2)) and 14 normal-weight (N; BMI = 19.9 ± 1.5 kg/m(2)) children participated in a 2-wk program consisting of an ad libitum high-fiber, low-fat diet and daily exercise (2-2.5 h). Fasting serum samples were taken pre- and postintervention for determination of lipids, glucose homeostasis, inflammatory cytokines, and adipokines. Only the O group lost weight (3.9%) but remained overweight/obese (32.3 ± 1.9 kg/m(2)). Both groups exhibited significant intervention-induced decreases (P < 0.05) in serum insulin (N: 52.5% vs. O: 28.1%; between groups, P = 0.38), homeostatic model assessment for insulin resistance (N: 53.1% vs. O: 28.4%, P = 0.43), leptin (N: 69.3% vs. O: 44.1%, P = 0.10), amylin (N: 28.7% vs. O: 26.1%, P = 0.80), resistin (N: 40.0% vs. O: 35.1%, P = 0.99), plasminogen activator-inhibitor-1 (N: 30.8% vs. O: 25.6%, P = 0.59), IL-6 (N: 58.8% vs. O: 48.5%, P = 0.78), IL-8 (N: 46.0% vs. O: 42.2%, P = 0.49), and TNFα (N: 45.8% vs. O: 40.8%, P = 0.99). No associations between indices of weight change and phenotypic changes were noted. A short-term, intensive lifestyle modification program is effective in ameliorating metabolic risk factors in N and O children. These results suggest that obesity per se was not the primary driver of the phenotypes noted and that dietary intake and physical inactivity induce the phenotypic abnormalities. These data may have implications for the weight loss-independent management of cardiometabolic risk in pediatric populations.
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

